Close Menu
Home » Jeffrey Radding

Jeffrey Radding

Feb 15, 2007
Premium
Jeffrey Radding has joined Epitome Biosystems as vice president for research and development, the company announced this week.
 
Prior to joining Epitome, Radding headed the Platform Biology Group at Eli Lilly. The group evaluated and implemented cell signaling approaches for drug discovery across multiple therapeutic areas.
 
Radding obtained his PhD in chemistry from Indiana University.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Bill to Ease Post-Conviction DNA Testing Access

The Oregon state Senate unanimously passed a bill that would make it easier for people convicted of crimes to initiate DNA testing of evidence, according to the Associated Press.

Ah, Feel Full Now

People reports that researchers have uncovered genetic variants that lead people to always feel full.

Life Insurers, Too, in Florida?

Florida state senators are to weigh a bill prohibiting life insurance companies from using genetic information in coverage decisions, according to Florida Politics.

This Week in Genome Research

In Genome Research this week: metagenomic sequencing assay that detects pathogens in cerebrospinal fluid, single-tube long fragment read approach, and more.

Apr
30
Featured Webinar

Novel Methods for Improving De Novo Transcriptome Annotation with Long-Read Transcript Sequencing

Sponsored by
Lexogen

This webinar will discuss novel long-read transcript sequencing (LRTseq) methods for transcriptome annotation that could increase the efficiency and accuracy of future sequencing projects.

What's Popular?

In Proteomics & Protein Research

  1. Roche Partners with Biognosys, Caprion to Demonstrate Proteomics Readiness for Clinical Trials

    Premium

  2. Blood Protein Signature Reported for Severe Diabetic Kidney Disease

  3. Waters Q1 Revenues Down 3 Percent

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.